Appendix B_Published 60dy FRN

Federal Register / Vol. 86, No. 15 / Tuesday, January 26, 2021 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–01693 Filed 1–25–21; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–21CG; Docket No. CDC–2021–
0004]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled A Longitudinal Examination of
Mental and Physical Health among
Police Associated with COVID–19. The
aim of this project is to evaluate the
longitudinal consequences of the
COVID–19 pandemic on the mental and
physical health of police officers.
DATES: CDC must receive written
comments on or before March 29, 2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0004 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
SUMMARY:

VerDate Sep<11>2014

20:59 Jan 25, 2021

Jkt 253001

the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
A Longitudinal Examination of
Mental and Physical Health among
Police Associated with COVID–19—
New—National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Police officers are exposed to several
stressors during their working lives,
including traumatic events (e.g., motorvehicle accidents, domestic incidents),
organizational stressors (e.g., long work

PO 00000

Frm 00036

Fmt 4703

Sfmt 4703

7095

hours, shiftwork), public criticism, and
concern about physical harm. On top of
these day-to-day stressors, the
coronavirus disease 2019 (COVID–19)
has contributed to an increase in mental
and physical risk. Although exact
figures are not known, in April 2020, it
was estimated that approximately 17%
of the New York police department were
out sick and five officers had died. Over
1000 police officers had tested positive
for COVID–19. Since then, rates of
COVID–19 have not only increased in
the general population, but also in
police populations. These preliminary
studies indicate that police departments
are under a great deal of stress and at
greater risk because of COVID–19. Given
that efficiently performing officers are
key to successful functioning of law
enforcement, addressing police mental
and physical health is imperative for
their well-being, as well as that of the
public they serve. Nonetheless, little
research has been conducted to evaluate
the physical and mental health
consequences of the COVID–19
pandemic on police officers. Thus,
NIOSH seeks OMB approval to evaluate
the longitudinal mental and physical
health effect of the COVID–19 pandemic
on police officers.
Previously, in collaboration with
NIOSH, the University of New York at
Buffalo (UB) conducted a cross-sectional
research project to evaluate the mental,
physical, and subclinical measures of
health in Buffalo, NY police officers as
part of the Buffalo Cardio-Metabolic
Occupational Police Stress (BCOPS)
study. The BCOPs study itself includes
a baseline examination and four followup examinations. For this reason,
NIOSH has mental and physical health
data on police officers collected prior to
COVID–19, including stress related
surveys, blood parameters, physical
measures, stress biomarkers (cortisol)
and telomere length data.
To meet the aims of the current study
NIOSH has contracted with UB to
recruit 200 police officers who
previously participated in a BCOPS
study. Priority will be placed on
recruiting officers who participated in
the last BCOPS study (n=240). If 200 of
the 240 officers cannot be recruited,
then UB will try to recruit any officer
who has previously participated in a
BCOPS study. A subset of the surveys
and biological data collected as part of
the BCOPS studies will be repeated for
this study. By comparing the responses
of the surveys and physical data
collected as part of BCOPS, prior to
COVID–19, to those obtained during this
study, NIOSH can evaluate the
longitudinal physical and psychological

E:\FR\FM\26JAN1.SGM

26JAN1

7096

Federal Register / Vol. 86, No. 15 / Tuesday, January 26, 2021 / Notices

health effects of COVID–19 on the
police officers.
To meet the aims of this study there
will be two rounds of data collection.
The first round will consist of collecting
both the mental and physical health
data. The second round, approximately
6–8 months later, will consist of
collecting the mental health and
medical history surveys only.
During the first round, letters will be
sent to officers who participated in the
previous BCOPS study asking them to
voluntarily participate in this study.
Once they agree, a letter of introduction
will be sent. If an officer hasn’t
responded after two letters have been
sent, UB will contact the officers by
phone. If the officer declines to
participate they will no longer be
contacted. For officers who agree to
participate, UB will coordinate the
scheduling of officers with the police
department and will not schedule
officers more than one month in
advance. Scheduling will be flexible.
At their designated appointment, all
participants will complete the paper
and pencil questionnaires then
complete the clinical exam, which will
entail a fasting blood draw
(approximately four tablespoons),
measuring the participants’ height,
weight, abdominal height, waist
circumference and neck circumference,

COVID questionnaire. The
psychological surveys will be the same
surveys they did during the first round,
while the COVID questionnaire asks
additional questions related to their
experience with COVID since the clinic
visit. They will not be asked to complete
the personal history questionnaire the
second time. This second set of
questionnaires allows NIOSH to meet
the study aims.
The burden table lists the estimated
population size of 200 police officers
who will respond to 16 psychosocial
questionnaires, serological (blood)
collection, and salivary cortisol at the
first round. All officers who participate
in the first round and who have agreed,
will be mailed the medical history
questionnaire and psychosocial
questionnaires 6–8 months later (second
round). Biological samples will not be
collected during the second round. We
anticipate that up to 10% of the
participants may not present for testing
during either the first round or second
round of questionnaires. Therefore, we
estimate that 180 officers will complete
both rounds of the data collection. The
total burden hours for all surveys,
serological sample collection, and
salivary cortisol is 547. There are no
costs to the respondents other than their
time.

and taking their blood pressure. Cortisol
saliva testing will be done outside of the
clinic at the participant’s residence by
the participant. Participants will be
provided with Salivettes (Sarstedt,
USA), a commercially available
collection device consisting of dental
rolls and centrifuge tubes, to take with
them when the leave the clinic for the
collection of saliva samples.
Participants will be given instructions
on how to collect the samples to be
taken the day after they leave the
clinic—four samples in the morning
when they awaken, one at lunchtime,
one at dinner, and one when the go to
sleep. The participant will be asked to
return the saliva samples to the clinic
when completed either in person or via
paid postage. This ends the clinic visit.
UB will advise the participant upon
departing during round one that they
would like to contact them again in
about 6–8 months to complete the same
surveys they did in the clinic.
For the second round, UB will
conduct a follow-up survey
approximately 6–8 months after the
clinic visit. Each officer who
participated in the first round and who
agreed to participate in the second
round, will be sent the same set of
psychological surveys, the medical
history questionnaire, and a follow-up

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Average
burden per
response
(in hours)

Total
burden
(in hours)

Type of respondents

Form name

Number of
respondents

Police officers .........

Personal history ..........................................................
Medical history ............................................................
Spielberger Stress Survey ..........................................
Center for Epidemiologic Studies Depression Scale ..
Brief Cope ...................................................................
Organizational Support Scale .....................................
Maslach Burnout .........................................................
Fatigue Scale ..............................................................
Posttraumatic Stress Disorder –5 ...............................
Connor-Davidson Resiliency Scale .............................
Beck Anxiety ...............................................................
Pittsburgh Sleep Quality Index ...................................
Beck Depression .........................................................
Beck Hopelessness .....................................................
COVID–19 (round 1) ...................................................
COVID–19 (round 2) ...................................................
Civil Unrest/Public Perception/work environment .......
Serological Sample collection .....................................
Salivary Cortisol collection ..........................................

180
180
180
180
180
180
180
180
180
180
180
........................
180
180
180
180
180
180
180

1
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
2
1
1

2/60
8/60
7/60
2/60
3/60
2/60
2/60
2/60
2/60
1/60
3/60
2/60
3/60
2/60
3/60
3/60
3/60
1
30/60

6
48
42
12
18
12
12
12
12
6
18
12
18
14
9
9
17
180
90

Total ................

......................................................................................

........................

........................

........................

547

VerDate Sep<11>2014

20:59 Jan 25, 2021

Jkt 253001

PO 00000

Frm 00037

Fmt 4703

Sfmt 4703

E:\FR\FM\26JAN1.SGM

26JAN1

7097

Federal Register / Vol. 86, No. 15 / Tuesday, January 26, 2021 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–01621 Filed 1–25–21; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-21–21CH; Docket No. CDC–2021–
0005]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Serological Assay Development:
Brucella spp. Rough Strains. This
proposed collection will involve
specimen collection and relevant
clinical information from individuals
exposed to rough strains of Brucella
spp., or cases of brucellosis due to
infection with rough strains of Brucella
spp.
DATES: CDC must receive written
comments on or before March 29, 2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0005 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
SUMMARY:

e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.

Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,

Proposed Project
Serological Assay Development:
Brucella spp. Rough Strains—New—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Brucellosis is a zoonotic disease
caused by Brucella spp., which are
Gram-negative, intracellular bacterial
pathogens. Annually, 500,000 human
cases of brucellosis occur worldwide.
Though isolation of the organism can
help identify the causative species of
infection, this method is not always
possible due to laboratory biosafety
capacity requirements and specimen
availability. In some of these instances,
serological methods are helpful for
diagnosis. Serial serological methods are
also useful for monitoring individuals
who have had known exposures to
smooth Brucella spp. for
seroconversion, which can help detect
potential infection and reduce time to
diagnosis and treatment.
The proposed data collection will
help to understand the frequency of
exposures to rough strain Brucella spp.
in the United States, identify specific
antigens associated with rough strain
Brucella infections, develop highsensitivity and high-specificity
serological diagnostic assays based on
recognition of these antigens, and to
better understand the human humoral
immune response to rough Brucella
strains. Data collected will be used to
create a bank of specimens to help
develop additional tools for safer and
more timely diagnosis of brucellosis
caused by rough strains of Brucella spp.
CDC will collect specimens and
medical/surveillance record abstractions
from individuals exposed to rough
strains of Brucella spp., and individuals
with confirmed diagnosis of brucellosis
as a result of infection from rough
strains of Brucella spp.
CDC requests approval for three years.
The estimated annualized burden hours
are 55. There is no cost to respondents
other than their time.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of respondent

Form name

Patient (specimen collection) ............

N/A ...................................................

VerDate Sep<11>2014

20:59 Jan 25, 2021

Jkt 253001

PO 00000

Frm 00038

Fmt 4703

Sfmt 4703

Number of
responses per
respondent

10

E:\FR\FM\26JAN1.SGM

1

26JAN1

Average
burden per
response
(in hours)

Total
burden
(in hours)
5

50